Iovance Biotherapeutics, Inc.
IOVA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $116 | $115 | $232 | $78 |
| Short-Term Investments | $208 | $165 | $240 | $426 |
| Receivables | $69 | $0 | $0 | $0 |
| Inventory | $52 | $10 | $0 | $0 |
| Other Curr. Assets | $12 | $17 | $7 | $4 |
| Total Curr. Assets | $457 | $308 | $479 | $508 |
| Property Plant & Equip (Net) | $164 | $177 | $178 | $170 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $282 | $229 | $0 | $0 |
| Long-Term Investments | $0 | $66 | $0 | $92 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $0 | $7 | $8 |
| Total NC Assets | $453 | $473 | $185 | $269 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $910 | $780 | $664 | $777 |
| Liabilities | – | – | – | – |
| Payables | $28 | $33 | $27 | $27 |
| Short-Term Debt | $13 | $8 | $13 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $82 | $69 | $52 | $57 |
| Total Curr. Liab. | $122 | $110 | $91 | $89 |
| LT Debt | $45 | $68 | $73 | $66 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $32 | $17 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $78 | $85 | $73 | $66 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $57 | $75 | $84 | $71 |
| Total Liabilities | $200 | $196 | $164 | $156 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,385 | -$2,012 | -$1,568 | -$1,172 |
| AOCI | -$1 | $3 | -$1 | -$1 |
| Other Equity | $3,096 | $2,594 | $2,069 | $1,795 |
| Total Equity | $710 | $585 | $500 | $622 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $910 | $780 | $664 | $777 |
| Net Debt | -$57 | -$39 | -$146 | -$7 |